Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iovance Biotherapeutics Inc (NQ: IOVA ) 8.330 +0.370 (+4.65%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 4,106,552 Open 8.070 Bid (Size) 8.300 (4) Ask (Size) 8.350 (10) Prev. Close 7.960 Today's Range 8.000 - 8.350 52wk Range 3.210 - 18.33 Shares Outstanding 279,832,722 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News How Is The Market Feeling About Iovance Biotherapeutics? July 22, 2024 Via Benzinga Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) July 19, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire Performance YTD +2.84% +2.84% 1 Month +2.08% +2.08% 3 Month -26.41% -26.41% 6 Month +3.09% +3.09% 1 Year +13.03% +13.03% More News Read More 7 ‘Death Cross’ Stocks That Could Be Contrarian Buys July 17, 2024 Via InvestorPlace Is Iovance Biotherapeutics a Millionaire Maker? July 14, 2024 Via The Motley Fool 3 Under-$10 Biotech Stocks That Could Make You Rich July 11, 2024 Via InvestorPlace What's Going On With Iovance Biotherapeutics Today? May 24, 2024 Via Benzinga Iovance Biotherapeutics's Options: A Look at What the Big Money is Thinking May 10, 2024 Via Benzinga Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday July 11, 2024 Via Benzinga Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma June 28, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire Is It Too Late to Buy Iovance Biotherapeutics Stock? June 28, 2024 Via The Motley Fool Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) June 21, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire 3 Top Penny Stocks to Skyrocket Your Wealth in 2024 June 21, 2024 Via InvestorPlace The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why June 10, 2024 Via The Motley Fool Oncotelic Therapeutics (OTC: OTLC) Inks Deal With Mosaic ImmunoEngineering To Sell Clinical-Stage Necroptosis Cancer Therapy Assets May 29, 2024 Via News Direct Exposures Product Safety Iovance Biotherapeutics to Present at Upcoming Conferences and Events May 24, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire 10 Health Care Stocks With Whale Alerts In Today's Session May 24, 2024 Via Benzinga Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting May 23, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire Bull Market Buys: 2 Growth Stocks to Own for the Long Run May 22, 2024 Via The Motley Fool Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) May 17, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire 4 Small-Cap Value Stocks That Could Go Parabolic May 16, 2024 Via The Motley Fool The 3 Most Undervalued Biotech Stocks to Buy in May 2024 May 11, 2024 Via InvestorPlace Why Iovance Stock Is Down 18% Today May 10, 2024 Via The Motley Fool 12 Health Care Stocks Moving In Friday's Intraday Session May 10, 2024 Via Benzinga IOVA Stock Earnings: Iovance Biotherapeutics Meets EPS, Misses Revenue for Q1 2024 May 09, 2024 Via InvestorPlace Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 10, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.